Biological characteristics and translational research of dental stem cells.
- Author:
Qianmin OU
1
;
Zhengshi LI
1
;
Luhan NIU
1
;
Qianhui REN
1
;
Xinyu LIU
1
;
Xueli MAO
1
;
Songtao SHI
1
Author Information
1. South China Center of Craniofacial Stem Cell Research, Hospital of Stomatology, Guanghua School of Stomatology, Sun Yatsen University & Guangdong Provincial Key Laboratory of Stomatology, Guangzhou 510055, China.
- Publication Type:English Abstract
- Keywords:
Dental stem cells;
Extracellular vesicles;
Immunomodulation;
Periodontal restoration;
Pulp regeneration
- MeSH:
Humans;
Dental Pulp/cytology*;
Translational Research, Biomedical;
Mesenchymal Stem Cells/cytology*;
Periodontal Ligament/cytology*;
Stem Cells/cytology*;
Regeneration;
Tooth, Deciduous/cytology*;
Cell Differentiation;
Tissue Engineering/methods*;
Regenerative Medicine
- From:
Journal of Peking University(Health Sciences)
2025;57(5):827-835
- CountryChina
- Language:Chinese
-
Abstract:
Dental stem cells (DSCs), a distinct subset of mesenchymal stem cells (MSCs), are isolated from dental tissues, such as dental pulp, exfoliated deciduous teeth, periodontal ligament, and apical papilla. They have emerged as a promising source of stem cell therapy for tissue regeneration and autoimmune disorders. The main types of DSCs include dental pulp stem cells (DPSCs), stem cells from human exfoliated deciduous teeth (SHED), periodontal ligament stem cells (PDLSCs), and stem cells from apical papilla (SCAP). Each type exhibits distinct advantages: easy access via minimally invasive procedures, multi-lineage differentiation potential, and excellent ethical acceptability. DSCs have demonstrated outstanding clinical efficacy in oral and maxillofacial regeneration, and their long-term safety has been verified. In oral tissue regeneration, DSCs are highly effective in oral tissue regeneration for critical applications such as the restoration of dental pulp vitality and periodontal tissue repair. A defining advantage of DSCs lies in their ability to integrate with host tissues and promote physiological regeneration, which render them a better option for oral tissue regenerative therapies. Beyond oral applications, DSCs also exhibit promising potential in the treatment of systemic diseases, including type Ⅱ diabetes and autoimmune diseases due to their immunomodulatory effects. Moreover, extracellular vesicles (EVs) derived from DSCs act as critical mediators for DSCs' paracrine functions. Possessing regulatory properties similar to their parental cells, EVs are extensively utilized in research targeting tissue repair, immunomodulation, and regenerative therapy-offering a "cell-free" strategy to mitigate the limitations associated with cell-based therapies. Despite these advancements, standardizing large-scale manufacturing, maintaining strict quality control, and clarifying the molecular mechanisms underlying the interaction of DSCs and their EVs with recipient tissues remain major obstacles to the clinical translation of these treatments into broad clinical use. Addressing these barriers will be critical to enhancing their clinical applicability and therapeutic efficacy. In conclusion, DSCs and their EVs represent a transformative approach in regenerative medicine, and increasing clinical evidence supports their application in oral and systemic diseases. Continuous innovation remains essential to unlocking the widespread clinical potential of DSCs.
